| EPF157 | Can podcasts be reliable sources for informing policy makers and general public on the lessons from AIDS for the COVID-19 pandemic? | E-poster | COVID-19 and politics, human rights, ethics or policy |
| EPF158 | Legal and human rights interventions for persons living with HIV, KVPs, other vulnerable and marginalized groups during COVID 19 lockdown 2020-21: Uganda Network on Law, Ethics and HIV/AIDS (UGANET) experience | E-poster | COVID-19 and politics, human rights, ethics or policy |
| EPF159 | Access to HIV care and treatment before and during the COVID-19 pandemic for Venezuelan migrants in four urban settings of Colombia | E-poster | Impact of COVID-19 on HIV risk and HIV care among refugees, migrants, asylum seekers and internally displaced persons |
| EPF160 | AMPF Strategy for Combination Prevention and rights-based care to migrants and refugees living with HIV during the Covid-19 pandemic | E-poster | Impact of COVID-19 on HIV risk and HIV care among refugees, migrants, asylum seekers and internally displaced persons |
| EPF161 | Water and food insecurity are linked with increased HIV vulnerabilities during the COVID-19 pandemic among urban refugee youth in Kampala, Uganda | E-poster | Impact of COVID-19 on HIV risk and HIV care among refugees, migrants, asylum seekers and internally displaced persons |
| EPF162 | Impact of COVID-19 on HIV treatment and care among refugees, a call for action, Uganda experience | E-poster | Impact of COVID-19 on HIV risk and HIV care among refugees, migrants, asylum seekers and internally displaced persons |
| EPF163 | Who is paying attention? The impact of COVID-19 laws on sex workers in Southern Africa | E-poster | Impact of COVID-19 on HIV risk and HIV care among refugees, migrants, asylum seekers and internally displaced persons |
| EPF164 | Sexual behaviours and condom use among young refugees in Acholi and West NileSub-Regions | E-poster | Impact of COVID-19 on HIV risk and HIV care among refugees, migrants, asylum seekers and internally displaced persons |
| EPLBA01 | Protective potential of non-neutralizing mAbs targeting immunodominant Env epitopes against tier-2 HIV-1 | E-poster | Humoral immunity (including broadly neutralizing antibodies), Antibodies and B cells |
| EPLBA02 | Analysis of the HVTN 702 Phase 2b-3 HIV-1 vaccine trial in South Africa assessing RV144 antibody and T cell correlates of HIV-1 acquisition risk | E-poster | Cellular immunity; T cell vaccines |